Skip to main content

CITADEL ADVISORS LLC

Position in ABEO — Abeona Therapeutics Inc.

CIK 1423053 MIAMI, FL

Position in ABEO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$250,149
-$422,397 QoQ
Shares Held
55,837
-56.2% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABEO Over Time

Shares Held

Position Value (USD)

Derivatives in ABEO

reported options exposure · as of Mar 31, 2026
CallValue
$919,296
CallShares
205,200
PutValue
$120,960
PutShares
27,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,974,653 across 374 Biotechnology names. ABEO ranks #293 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABEO

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $120,960 27,000
2026-03-31 $250,149 55,837
2026-03-31 $919,296 205,200
2025-12-31 $303,025 57,500
2025-12-31 $442,680 84,000
2025-12-31 $672,546 127,618
2025-09-30 $1,443,794 273,446
2025-09-30 $334,752 63,400
2025-06-30 $444,744 78,300
2025-03-31 $152,529 32,044
2025-03-31 $26,656 5,600
2025-03-31 $58,072 12,200
2024-12-31 $16,153 2,900
2024-12-31 $44,560 8,000
2024-12-31 $7,140 1,282
2024-09-30 $113,760 18,000
2024-09-30 $4,480 709
2024-09-30 $218,672 34,600
2024-06-30 $114,056 26,900
2024-06-30 $167,480 39,500
2024-06-30 $17,935 4,230
2024-03-31 $82,650 11,400
2024-03-31 $29 4
2024-03-31 $286,375 39,500
2023-12-31 $43,086 8,600
2023-12-31 $456,511 91,120
2023-12-31 $53,106 10,600